Both optoacoustic and optical imaging are biophotonic imaging technologies. While optoacoustic imaging yields information about light absorption from both endogenous tissue chromophores and optical contrast agents, optical imaging only provides information from extrinsically administered agents by means of light emission (fluorescence or bioluminescence). In terms of performance, optical imaging can serve as an easy-to-use screening tool with limited resolution and depth penetration, while optoacoustic imaging can probe biological questions in more detail and at greater depth. In this webinar, hear 10-minute presentations from three leading scientists who utilize both complementary imaging methods to study diseases on a molecular level, across three different applications:
- Cancer: Judith Weber PhD, University of Cambridge
- Inflammation: Alexa Hasenbach, University of Münster
- Diabetes: Dr Sheryl Roberts, Memorial Sloan Kettering
iThera Medical’s upcoming webinar on May 20, 2020, will take place at 3:00 PM BST/ 4:00 PM CEST / 10:00 AM EDT. Sign up here.